Angiodynamics Offers $220M To Buy RITA Medical

Photo of Douglas A. McIntyre
By Douglas A. McIntyre Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

From BioHealth Investor

Shares of RITA Medical Systems (RITA) jumped 3% on higher volume last Friday with no news. This prompted BioHealth Investor to issue a Watch Alert on RITA shares over the weekend.

Then early Tuesday AngioDynamics, Inc (ANGO) made an offer to buyout RITA for $220 million, including the assumption of $3 million of debt.

RITA, a medical device developer and marketer of ablation and other surgical instruments, should complement ANGO’s peripheral vascular device business very well.

http://www.biohealthinvestor.com/

Both companies have had tremendous sales growth over the last three years, but RITA has had problems reducing its yearly net loss. AngioDynamics has seen an increasing bottom line and cash flow on a yearly basis.

With $89 million in cash and only about $3 million in debt AngioDynamics should have no problem affording the price tag since this deal is a cash and stock offer. Company executives believe that the acquisition should be neutral by mid 2007, and to add about $0.05 to its bottom line by 2008.

This deal makes sense. RITA is rescued from its debt and lack of profit growth, and AngioDynamics grabs hold of exciting surgical ablation and other surgical devices. AngioDynamics also adds RITA’s 30 strong sales force to its 50 sales persons, thereby increasing its sales potential by 60%. Both companies’ products do not overlap each other as well.

RITA made BHI’s Watch List last Friday.

Photo of Douglas A. McIntyre
About the Author Douglas A. McIntyre →

Douglas A. McIntyre is the co-founder, chief executive officer and editor in chief of 24/7 Wall St. and 24/7 Tempo. He has held these jobs since 2006.

McIntyre has written thousands of articles for 24/7 Wall St. He is an expert on corporate finance, the automotive industry, media companies and international finance. He has edited articles on national demographics, sports, personal income and travel.

His work has been quoted or mentioned in The New York Times, The Wall Street Journal, Los Angeles Times, The Washington Post, NBC News, Time, The New Yorker, HuffPost USA Today, Business Insider, Yahoo, AOL, MarketWatch, The Atlantic, Bloomberg, New York Post, Chicago Tribune, Forbes, The Guardian and many other major publications. McIntyre has been a guest on CNBC, the BBC and television and radio stations across the country.

A magna cum laude graduate of Harvard College, McIntyre also was president of The Harvard Advocate. Founded in 1866, the Advocate is the oldest college publication in the United States.

TheStreet.com, Comps.com and Edgar Online are some of the public companies for which McIntyre served on the board of directors. He was a Vicinity Corporation board member when the company was sold to Microsoft in 2002. He served on the audit committees of some of these companies.

McIntyre has been the CEO of FutureSource, a provider of trading terminals and news to commodities and futures traders. He was president of Switchboard, the online phone directory company. He served as chairman and CEO of On2 Technologies, the video compression company that provided video compression software for Adobe’s Flash. Google bought On2 in 2009.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618